Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYTO-PV: Intensity of Cytoreductive Therapy in Polycythemia Vera
NCT01645124Phase 3Terminated
- Sponsor
- Consorzio Mario Negri Sud
- Start
- May 2008
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxyurea in polycythemia vera (PV), sponsored by Consorzio Mario Negri Sud. Started May 2008; status: terminated.
02
Drugs
hydroxyurea
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT01645124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01645124.